I-Mab (IMAB)
NASDAQ: IMAB · IEX Real-Time Price · USD
1.580
-0.040 (-2.47%)
At close: Jul 2, 2024, 4:00 PM
1.570
-0.010 (-0.63%)
After-hours: Jul 2, 2024, 7:43 PM EDT
I-Mab Market Cap
I-Mab has a market cap or net worth of $121.70 million as of July 2, 2024. Its market cap has decreased by -51.92% in one year.
Market Cap
121.70M
Enterprise Value
-182.22M
1-Year Change
-51.92%
Ranking
Category
Stock Price
$1.58
Market Cap Chart
Since January 17, 2020, I-Mab's market cap has decreased from $720.80M to $121.70M, a decrease of -83.12%. That is a compound annual growth rate of -32.91%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 1, 2024 | 130.70M | -16.75% |
Dec 29, 2023 | 157.00M | -54.81% |
Dec 30, 2022 | 347.40M | -90.48% |
Dec 31, 2021 | 3.65B | 33.77% |
Dec 31, 2020 | 2.73B | 278.27% |
Jan 17, 2020 | 720.80M | - |
View and export this data all the way back to 2020.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Adagene | 131.91M |
Invivyd | 131.25M |
CervoMed | 130.82M |
G1 Therapeutics | 128.09M |
Cellectis | 125.41M |
Electromed | 121.18M |
Harvard Bioscience | 121.17M |
Compass Therapeutics | 121.08M |